Apollo Hospitals shares extend slide on weak Q4 earnings

We believe the current valuation of Apollo Hospitals Enterprises to an extent captures the prospects of longer term growth and ROIC (return on invested capital) improvement, brokerage house Nomura said in its note to clients
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead Masteryourmoney Earnings
moneycontrol.com

Home » News » Business

May 22, 2013, 03.21 PM | Source: Moneycontrol.com

Apollo Hospitals shares extend slide on weak Q4 earnings

We believe the current valuation of Apollo Hospitals Enterprises to an extent captures the prospects of longer term growth and ROIC (return on invested capital) improvement, brokerage house Nomura said in its note to clients

Like this story, share it with millions of investors on M3

Apollo Hospitals shares extend slide on weak Q4 earnings

We believe the current valuation of Apollo Hospitals Enterprises to an extent captures the prospects of longer term growth and ROIC (return on invested capital) improvement, brokerage house Nomura said in its note to clients

Post Your Comments

Share Cancel

Moneycontrol Bureau

Shares of Apollo Hospitals continued their slide Wednesday, shedding nearly 3 percent to Rs 948.50 after the company’s fourth quarter earnings announced on Monday fell short of market expectations.

Brokerage house Nomura downgraded the stock to neutral and also cut its revenue and net profit estimates for FY15 by 4-16 percent.

Also Read: Apollo Hospitals Q4 net up 27% at Rs 75.5cr on tax benefit

"Slippage in earnings, slower-than estimated growth in ARPOB (average revenue per occupied bed) and some delay in execution contribute to a 1416% cut in our earnings estimates," said the Nomura note to clients.

"We believe the current valuation to an extent captures the prospects of longer term growth and ROIC (return on invested capital) improvement. We remain constructive the over long term, but await a better entry point," the note added.

Nomura has a price target of Rs 933 for the stock, and does not see the weak fourth quarter numbers as a cause for concern.

"4Q was weak due to a bunching up of holidays and start-up costs related to two new hospitals. Expansion plans are however on track, business outlook remains strong and funding is not a concern," the Citi note to clients said.

Citi has a target price of Rs 960 for the stock.

Apollo shares had rallied nearly 40 percent in less than 2 months between March and May this year. The stock's inclusion in the MSCI India Index contributed to the positive sentiment in a major way.

"After the recent stock rally and weak operational performance, we believe the stock offers limited margin of safety," brokerage house Kotak Securities said in a note to clients.

Ads by Google

Buy, Hold, Sell ? Hear it first on M3
Apollo Hospitals shares extend slide on weak Q4 earnings

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login